Mark Plavsic - 16 Oct 2025 Form 4 Insider Report for Aura Biosciences, Inc. (AURA)

Role
Chief Technology Officer
Signature
/s/ Conor Kilroy, as Attorney-in-Fact
Issuer symbol
AURA
Transactions as of
16 Oct 2025
Net transactions value
-$77,273
Form type
4
Filing time
16 Oct 2025, 17:44:01 UTC
Previous filing
18 Feb 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Plavsic Mark Chief Technology Officer C/O AURA BIOSCIENCES, INC., 80 GUEST STREET, BOSTON /s/ Conor Kilroy, as Attorney-in-Fact 16 Oct 2025 0001868719

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AURA Common Stock Sale $77,273 -12,169 -5.8% $6.35 197,287 16 Oct 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.